Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ACET Adicet Bio Inc
- Stocks
- Healthcare
- NASDAQ: ACET
Price (delayed)
$0.6099
Market cap
$50.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.29
Enterprise value
$35.65M
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta
Highlights
ACET's EPS has surged by 56% year-on-year and by 3% since the previous quarter
Adicet Bio's debt has decreased by 19% YoY and by 6% QoQ
Adicet Bio's equity has decreased by 38% YoY and by 13% QoQ
The quick ratio has decreased by 34% YoY
Key stats
What are the main financial stats of ACET
Market
Valuations
Earnings
Shares outstanding
82.71M
Market cap
$50.44M
Enterprise value
$35.65M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.31
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$126.63M
Net income
-$117.32M
EBIT
-$117.32M
EBITDA
-$107.56M
Free cash flow
-$97.3M
Per share
Balance sheet
Liquidity
EPS
-$1.29
EPS diluted
-$1.29
Free cash flow per share
-$1.07
Book value per share
$1.95
Revenue per share
$0
TBVPS
$2.1
Total assets
$191.27M
Total liabilities
$29.83M
Debt
$16.25M
Equity
$161.45M
Working capital
$137.12M
Debt to equity
0.1
Current ratio
9.34
Quick ratio
9.32
Net debt/EBITDA
0.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-50.7%
Return on equity
-59.1%
Return on invested capital
-93.1%
Return on capital employed
-67.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ACET stock price
How has the Adicet Bio stock price performed over time
Intraday
27.49%
1 week
-8.97%
1 month
17.29%
1 year
-62.58%
YTD
-36.6%
QTD
-19.22%
Financial performance
How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$126.63M
Net income
-$117.32M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 16% YoY
ACET's operating income is up by 15% YoY
Price vs fundamentals
How does ACET's price correlate with its fundamentals
Growth
What is Adicet Bio's growth rate over time
Valuation
What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.31
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS has surged by 56% year-on-year and by 3% since the previous quarter
ACET's price to book (P/B) is 72% lower than its 5-year quarterly average of 1.1 and 23% lower than its last 4 quarters average of 0.4
Adicet Bio's equity has decreased by 38% YoY and by 13% QoQ
Efficiency
How efficient is Adicet Bio business performance
Adicet Bio's ROIC has soared by 66% YoY and by 22% from the previous quarter
ACET's ROE is down by 13% QoQ but it is up by 9% YoY
Adicet Bio's return on assets has decreased by 11% QoQ but it has increased by 8% YoY
Dividends
What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ACET.
Financial health
How did Adicet Bio financials performed over time
The company's total assets fell by 35% YoY and by 13% QoQ
ACET's current ratio is down by 35% year-on-year
Adicet Bio's debt is 90% lower than its equity
Adicet Bio's equity has decreased by 38% YoY and by 13% QoQ
ACET's debt to equity is up by 25% YoY and by 11% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.